STATE-OF-THE-ART PAPER
The quantification of infarct size
Raymond J. Gibbons, MD*,*,
Uma S. Valeti, MD*,
Philip A. Araoz, MD and
Allan S. Jaffe, MD*
* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
Department of Radiology, Mayo Clinic and Foundation, Rochester, Minnesota
Manuscript received January 22, 2004;
revised manuscript received June 7, 2004,
accepted June 14, 2004.
* Reprint requests and correspondence: Dr. Raymond J. Gibbons, Mayo Clinic, Gonda 5, 200 First Street, SW, Rochester, Minnesota 55905 (Email: gibbons.raymond{at}mayo.edu).
We sought to summarize the published evidence regarding the measurement of infarct size by serum markers, technetium-99m sestamibi single-photon emission computed tomography (SPECT) myocardial perfusion imaging, and magnetic resonance imaging. The measurement of infarct size is an attractive surrogate end point for the early assessment of new therapies for acute myocardial infarction. For each of these three approaches, we reviewed reports published in English providing the clinical validation for the measurement of infarct size and the relevant clinical trial experience. The measurement of infarct size by serum markers has multiple theoretical and practical limitations. The measurement of troponin is promising, but the available data validating this marker are limited. Sestamibi SPECT imaging has five separate lines of published evidence supporting its validity and has received extensive study in multicenter trials. Magnetic resonance imaging has great promise but has less clinical validation and no multicenter trial experience. Therefore, SPECT sestamibi imaging is currently the best available technique for the quantitation of infarct size to assess the incremental treatment benefit of new therapies in multicenter trials of acute myocardial infarction.
|
Abbreviations and Acronyms
| | CK = creatine kinase | | CK-MB = creatine kinase-MB fraction | | HBDH = hydroxybutyrate dehydrogenase | | MI = myocardial infarction | | MRI = magnetic resonance imaging | | SPECT = single-photon emission computed tomography | | Tc = technetium |
|
This article has been cited by other articles:
|
|
|
|
 
L. Gomez, B. Li, N. Mewton, I. Sanchez, C. Piot, M. Elbaz, and M. Ovize
Inhibition of mitochondrial permeability transition pore opening: translation to patients
Cardiovasc Res,
July 15, 2009;
83(2):
226 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Carlsson, J. F.A. Ubachs, E. Hedstrom, E. Heiberg, S. Jovinge, and H. Arheden
Myocardium at risk after acute infarction in humans on cardiac magnetic resonance quantitative assessment during follow-up and validation with single-photon emission computed tomography.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
569 - 576.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Majidi, A. S. Kosinski, S. M. Al-Khatib, M. E. Lemmert, L. Smolders, A. van Weert, J. H.C. Reiber, D. Tzivoni, F. W.H.M. Bar, H. J.J. Wellens, et al.
Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
Eur. Heart J.,
April 1, 2009;
30(7):
757 - 764.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Habis, A Capderou, A Sigal-Cinqualbre, S Ghostine, S Rahal, J Y Riou, P Brenot, C Y Angel, and J F Paul
Comparison of delayed enhancement patterns on multislice computed tomography immediately after coronary angiography and cardiac magnetic resonance imaging in acute myocardial infarction
Heart,
April 1, 2009;
95(8):
624 - 629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Camici and O. E. Rimoldi
A Novel 18F-Labeled Tracer for the Quantification of Myocardial Blood Flow and Infarct Size With Positron-Emission Tomography: Another Way to Avoid the Need of an On-Site Cyclotron
Circ Cardiovasc Imaging,
March 1, 2009;
2(2):
75 - 76.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Sherif, A. Saraste, E. Weidl, A. W. Weber, T. Higuchi, S. Reder, T. Poethko, G. Henriksen, D. Casebier, S. Robinson, et al.
Evaluation of a Novel 18F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in Rats
Circ Cardiovasc Imaging,
March 1, 2009;
2(2):
77 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Saenger and A. S. Jaffe
Requiem for a Heavyweight: The Demise of Creatine Kinase-MB
Circulation,
November 18, 2008;
118(21):
2200 - 2206.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chia, F. Senatore, O. C. Raffel, H. Lee, F. J. Th. Wackers, and I.-K. Jang
Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv.,
August 1, 2008;
1(4):
415 - 423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T. T. Cung, E. Bonnefoy, D. Angoulvant, et al.
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
N. Engl. J. Med.,
July 31, 2008;
359(5):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H.M. Jansen, F. Bracke, J. m. van Dantzig, K. H. Peels, J. C. Post, H. C.M. van den Bosch, B. van Gelder, A. Meijer, H. H.M. Korsten, J. de Vries, et al.
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy
Eur J Echocardiogr,
July 1, 2008;
9(4):
483 - 488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E Wu, J T Ortiz, P Tejedor, D C Lee, C Bucciarelli-Ducci, P Kansal, J C Carr, T A Holly, D Lloyd-Jones, F J Klocke, et al.
Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study
Heart,
June 1, 2008;
94(6):
730 - 736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Fleming and G. M. Harrington
What Is the Relationship Between Myocardial Perfusion Imaging and Coronary Artery Disease Risk Factors and Markers of Inflammation?
Angiology,
March 1, 2008;
59(1):
16 - 25.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. C. Vasile, L. Babuin, E. Giannitsis, H. A. Katus, and A. S. Jaffe
Relationship of MRI-Determined Infarct Size and cTnI Measurements in Patients with ST-Elevation Myocardial Infarction
Clin. Chem.,
March 1, 2008;
54(3):
617 - 619.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T. T. Cung, E. Bonnefoy, D. Angoulvant, J.-F. Aupetit, et al.
Long-Term Benefit of Postconditioning
Circulation,
February 26, 2008;
117(8):
1037 - 1044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Kim, T. S.E. Albert, J. H. Wible, M. D. Elliott, J. C. Allen, J. C. Lee, M. Parker, A. Napoli, R. M. Judd, and for the Gadoversetamide Myocardial Infarction Imag
Performance of Delayed-Enhancement Magnetic Resonance Imaging With Gadoversetamide Contrast for the Detection and Assessment of Myocardial Infarction: An International, Multicenter, Double-Blinded, Randomized Trial
Circulation,
February 5, 2008;
117(5):
629 - 637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Giannitsis, H. Steen, K. Kurz, B. Ivandic, A. C. Simon, S. Futterer, C. Schild, P. Isfort, A. S. Jaffe, and H. A. Katus
Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T
J. Am. Coll. Cardiol.,
January 22, 2008;
51(3):
307 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Heiberg, M. Ugander, H. Engblom, M. Gotberg, G. K. Olivecrona, D. Erlinge, and H. Arheden
Automated Quantification of Myocardial Infarction from MR Images by Accounting for Partial Volume Effects: Animal, Phantom, and Human Study
Radiology,
December 13, 2007;
(2007)
2461062164.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Carstensen, G. C.I. Nelson, P. S. Hansen, L. Macken, S. Irons, M. Flynn, P. Kovoor, S. Y. Soo Hoo, M. R. Ward, and H. H. Rasmussen
Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome
Eur. Heart J.,
October 1, 2007;
28(19):
2313 - 2319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Liu, R. B. Marchase, and J. C. Chatham
Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1391 - H1399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. De Bruyne and G. R. Heyndrickx
Changes in Infarct Size and Left Ventricular Ejection Fraction: New Prognostic Factors After Acute Myocardial Infarction?
J. Am. Coll. Cardiol.,
July 10, 2007;
50(2):
157 - 158.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ndrepepa, J. Mehilli, S. Martinoff, M. Schwaiger, A. Schomig, and A. Kastrati
Evolution of Left Ventricular Ejection Fraction and its Relationship to Infarct Size After Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
July 10, 2007;
50(2):
149 - 156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thiele, M. J. Kappl, A. Linke, S. Erbs, E. Boudriot, A. Lembcke, D. Kivelitz, and G. Schuler
Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging
Eur. Heart J.,
June 6, 2007;
(2007)
ehm173v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
Cardiovasc Res,
June 1, 2007;
74(3):
343 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Vartdal, H. Brunvand, E. Pettersen, H.-J. Smith, E. Lyseggen, T. Helle-Valle, H. Skulstad, H. Ihlen, and T. Edvardsen
Early Prediction of Infarct Size by Strain Doppler Echocardiography After Coronary Reperfusion
J. Am. Coll. Cardiol.,
April 24, 2007;
49(16):
1715 - 1721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Maioli, F. Bellandi, M. Leoncini, A. Toso, and R. P. Dabizzi
Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial)
J. Am. Coll. Cardiol.,
April 10, 2007;
49(14):
1517 - 1524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Higuchi, S. G. Nekolla, A. Jankaukas, A. W. Weber, M. C. Huisman, S. Reder, S. I. Ziegler, M. Schwaiger, and F. M. Bengel
Characterization of Normal and Infarcted Rat Myocardium Using a Combination of Small-Animal PET and Clinical MRI
J. Nucl. Med.,
February 1, 2007;
48(2):
288 - 294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ibrahim, H. P. Bulow, T. Hackl, M. Hornke, S. G. Nekolla, M. Breuer, A. Schomig, and M. Schwaiger
Diagnostic Value of Contrast-Enhanced Magnetic Resonance Imaging and Single-Photon Emission Computed Tomography for Detection of Myocardial Necrosis Early After Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
208 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Steen, E. Giannitsis, S. Futterer, C. Merten, C. Juenger, and H. A. Katus
Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2192 - 2194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kaltoft, M. Bottcher, S. S. Nielsen, H.-H. T. Hansen, C. Terkelsen, M. Maeng, J. Kristensen, L. Thuesen, L. R. Krusell, S. D. Kristensen, et al.
Routine Thrombectomy in Percutaneous Coronary Intervention for Acute ST-Segment-Elevation Myocardial Infarction: A Randomized, Controlled Trial
Circulation,
July 4, 2006;
114(1):
40 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Numaguchi, T. Sone, K. Okumura, M. Ishii, Y. Morita, R. Kubota, K. Yokouchi, H. Imai, M. Harada, H. Osanai, et al.
The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction
Circulation,
July 4, 2006;
114(1_suppl):
I-114 - I-119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wagner, H. Mahrholdt, L. Thomson, S. Hager, G. Meinhardt, W. Rehwald, M. Parker, D. Shah, U. Sechtem, R. J. Kim, et al.
Effects of Time, Dose, and Inversion Time for Acute Myocardial Infarct Size Measurements Based on Magnetic Resonance Imaging-Delayed Contrast Enhancement
J. Am. Coll. Cardiol.,
May 16, 2006;
47(10):
2027 - 2033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thiele, M. J.E. Kappl, S. Conradi, J. Niebauer, R. Hambrecht, and G. Schuler
Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-Magnetic Resonance Imaging
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1641 - 1645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Ross, R. J. Gibbons, G. W. Stone, R. A. Kloner, and R. W. Alexander
Reply
J. Am. Coll. Cardiol.,
March 21, 2006;
47(6):
1236 - 1237.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tarantini, L. Cacciavillani, F. Corbetti, A. Ramondo, M. P. Marra, E. Bacchiega, M. Napodano, C. Bilato, R. Razzolini, and S. Iliceto
Duration of Ischemia Is a Major Determinant of Transmurality and Severe Microvascular Obstruction After Primary Angioplasty: A Study Performed With Contrast-Enhanced Magnetic Resonance
J. Am. Coll. Cardiol.,
October 4, 2005;
46(7):
1229 - 1235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Staat, G. Rioufol, C. Piot, Y. Cottin, T. T. Cung, I. L'Huillier, J.-F. Aupetit, E. Bonnefoy, G. Finet, X. Andre-Fouet, et al.
Postconditioning the Human Heart
Circulation,
October 4, 2005;
112(14):
2143 - 2148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gick, N. Jander, H.-P. Bestehorn, R.-P. Kienzle, M. Ferenc, K. Werner, T. Comberg, K. Peitz, D. Zohlnhofer, V. Bassignana, et al.
Randomized Evaluation of the Effects of Filter-Based Distal Protection on Myocardial Perfusion and Infarct Size After Primary Percutaneous Catheter Intervention in Myocardial Infarction With and Without ST-Segment Elevation
Circulation,
September 6, 2005;
112(10):
1462 - 1469.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons and C. L. Grines
Acute PCI for ST-Segment Elevation Myocardial Infarction: Is Later Better Than Never?
JAMA,
June 15, 2005;
293(23):
2930 - 2932.
[Full Text]
[PDF]
|
|
|
|
